Wedbush Reiterates Outperform on IBM, Maintains $320 Price Target

Benzinga Newsdesk www.benzinga.com Negative 92.2%

Neg 92.2% Neu 0% Pos 0%

Wedbush analyst Dan Ives reiterates IBM (NYSE:IBM) with a Outperform and maintains $320 price target.

Comments

No comments yet. Be the first!